NASDAQ:SLS

Sellas Life Sciences Group Stock Predictions

etoro logo Buy SLS
*Your capital is at risk
$8.23
-0.81 (-8.96%)
At Close: Jun 05, 2026
Currently predicting for Mon, 8 Jun 2026

SLS Prediction Chart

SLS Predictions History

Latest community submissions for SLS.
Predictor Target Session Target Price Result Direction Accuracy Score
Dec 29, 2025 $2.82 -1.73% $3.35 X 84.19% 0
Dec 26, 2025 $2.76 -2.75% $2.87 X 96.23% 0
Dec 26, 2025 $2.79 -1.72% $2.87 X 97.25% 0
Bengal Fan Bengal Fan @BengalFan.176041
Dec 24, 2025 Bullish $2.84 V 1
Dec 18, 2025 $2.05 -3.02% $2.34 X 87.45% 0
Dec 18, 2025 $2.07 -1.89% $2.34 X 88.47% 0
Dec 17, 2025 $2.14 -2.85% $2.11 V 98.71% 2
Dec 17, 2025 $2.16 -1.78% $2.11 V 97.60% 1
Dec 15, 2025 $1.98 -2.87% $2.05 X 96.65% 0
Dec 15, 2025 $2.00 -1.80% $2.05 X 97.72% 0
Click to get the best stock tips daily for free!
Forecast Desk

Request A 3-Month Forecast

Ask an approved predictor to map the next 66 trading days for SLS with a full price path, not just a one-day call.
  • Price path
  • Approved predictor
  • 3-month horizon
ABOUT SELLAS LIFE SCIENCES GROUP INC.
SELLAS Life Sciences Group
SELLAS Life Sciences Group, Inc., a late-stage biopharmaceutical company, focuses on the development of novel cancer immunotherapies for various cancer indications in the United States. Its lead product candidate is galinpepimut-S (GPS), a cancer immunotherapeutic agent that targets Wilms tumor 1, which is in Phase III clinical trials for the treatment of acute myeloid leukemia; and in Phase 1/2 clinical trials for the treatment for ovarian cance...
GOLDEN STAR
Ticker Change Signal Date
FISV
0% Nov 30
K
KEEL
0% Nov 30
D
DFTX
0% Nov 30
R
RKLZ
0% Nov 30
R
RKTO
0% Nov 30

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE